Jointown Pharmaceutical Group Co., Ltd (SHA: 600998)

Jointown Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16,250	16,949	17,176	14,702	14,809	12,171
Short-Term Investments	73.24	95.01	90	289.15	103.76	12.3
Trading Asset Securities	58.18	90.03	319.72	3,597	15.31	-
Cash & Short-Term Investments	16,381	17,134	17,586	18,588	14,928	12,184
Cash Growth	1.64%	-2.57%	-5.39%	24.51%	22.53%	-4.07%
Accounts Receivable	37,205	29,375	30,511	28,224	27,269	24,448
Other Receivables	2,417	2,905	2,395	3,029	5,245	4,620
Receivables	39,623	32,280	32,907	31,305	32,514	29,068
Inventory	18,219	20,114	17,213	15,517	14,775	14,072
Prepaid Expenses	17.41	-	-	22.94	5.22	-
Other Current Assets	6,801	6,097	7,952	5,737	3,927	3,579
Total Current Assets	81,040	75,625	75,658	71,170	66,150	58,903
Property, Plant & Equipment	9,081	8,963	8,648	8,521	7,413	6,505
Long-Term Investments	3,722	3,552	3,298	2,413	3,723	2,562
Goodwill	785.4	759.68	813.38	581.43	554.33	342.52
Other Intangible Assets	1,897	1,895	1,863	2,195	2,257	2,198
Long-Term Accounts Receivable	-	-	-	-	1.95	0.9
Long-Term Deferred Tax Assets	486.92	476.42	434.7	288.42	245.67	204.52
Long-Term Deferred Charges	353.23	283.7	261.01	196.38	122.65	128.38
Other Long-Term Assets	1,339	1,233	1,336	570.62	355.48	303.78
Total Assets	98,705	92,789	92,312	85,936	80,824	71,148
Accounts Payable	43,534	40,101	39,295	34,158	31,099	28,019
Accrued Expenses	644.96	786.92	780.82	631.62	446.55	374.4
Short-Term Debt	13,637	10,122	11,493	13,055	14,325	11,707
Current Portion of Long-Term Debt	1,515	2,040	413.42	1,767	-	97
Current Portion of Leases	75.57	78.65	79.21	87.16	-	-
Current Income Taxes Payable	223.69	267.28	306.73	178.7	349.96	250.65
Current Unearned Revenue	991.91	1,704	2,502	966.06	929.71	714.65
Other Current Liabilities	4,679	4,966	4,814	4,551	4,182	4,784
Total Current Liabilities	65,301	60,066	59,684	55,394	51,332	45,948
Long-Term Debt	1,903	2,336	2,980	2,379	3,205	2,724
Long-Term Leases	170.95	170.99	195.64	180.29	-	-
Long-Term Unearned Revenue	367.67	360.7	306.49	343.39	317.41	190.04
Long-Term Deferred Tax Liabilities	370.81	378.47	459.6	566.11	352.26	120.26
Other Long-Term Liabilities	-	-	-	-	-	198.26
Total Liabilities	68,114	63,312	63,626	58,863	55,207	49,180
Common Stock	5,042	3,909	1,874	1,874	1,874	1,878
Additional Paid-In Capital	5,210	6,353	8,205	8,056	8,095	8,131
Retained Earnings	14,285	14,054	12,950	11,546	10,155	7,181
Treasury Stock	-457.4	-581.86	-774.24	-614.82	-858.06	-805.21
Comprensive Income & Other	257.8	248.37	402.59	564.73	578.67	2,370
Total Common Equity	24,338	23,983	22,657	21,426	19,844	18,754
Minority Interest	6,253	5,494	4,046	3,664	3,790	3,213
Shareholders' Equity	30,591	29,477	28,685	27,073	25,617	21,968
Total Liabilities & Equity	98,705	92,789	92,312	85,936	80,824	71,148
Total Debt	17,302	14,747	15,162	17,469	17,530	14,528
Net Cash (Debt)	-920.29	2,387	2,424	1,119	-2,602	-2,344
Net Cash Growth	-	-1.52%	116.56%	-	-	-
Net Cash Per Share	-0.19	0.47	0.46	0.22	-0.49	-0.42
Filing Date Shares Outstanding	4,706	5,193	4,912	4,963	4,921	6,913
Total Common Shares Outstanding	4,706	5,193	4,945	4,963	4,921	6,913
Working Capital	15,739	15,559	15,973	15,775	14,818	12,955
Book Value Per Share	5.17	4.62	4.54	4.28	3.99	2.44
Tangible Book Value	21,656	21,328	19,981	18,649	17,032	16,214
Tangible Book Value Per Share	4.60	4.11	4.00	3.72	3.42	2.07
Buildings	8,837	8,235	7,515	6,536	5,589	5,118
Machinery	3,293	3,219	2,965	2,779	2,451	2,216
Construction In Progress	313.25	634.92	865.37	1,523	1,682	1,144

Source: S&P Capital IQ. Standard template. Financial Sources.